“We recommend Metformin as primary treatment for oral drug of diabetes type II”

It was suggested ‘Metformin’ must be primarily used as an oral single-substance drug for the treatment of diabetes type II.

The Korean Diabetes Association(Chairman Moon-Gyu Lee), on the 28^th, held a press conference to celebrate the ‘ICDM2017,’ an international academic symposium for diabetes and endocrinology, and introduced the recently-revised ‘Diabetes Type II Drug Treatment Guideline.’